Erythrocyte encapsulated l-asparaginase (GRASPA) in acute leukemia. - Abstract - Europe PMC
Asparaginase: an old drug with new questions - ScienceDirect
Clinical Characteristics of Intravenous PEG-Asparaginase Hypersensitivity Reactions in Patients Undergoing Treatment for Acute Lymphoblastic Leukemia - Emily K. Browne, Christina Moore, April Sykes, Zhaohua Lu, Sima Jeha, Belinda N. Mandrell, 2018
Managing asparaginase-related toxicity in adult patients - Oncology Nurse Advisor
Consensus expert recommendations for identification and management of asparaginase hypersensitivity and silent inactivation | Haematologica
Cancers | Free Full-Text | Novel Insights on the Use of L-Asparaginase as an Efficient and Safe Anti-Cancer Therapy
Detecting and Treating Asparaginase-Related Toxicities in Acute Lymphoblastic Leukemia (Transcript)
AEA measurements and 95% CI over time in the groups; Allergic reaction... | Download Scientific Diagram
Cost-analysis of treatment of childhood acute lymphoblastic leukemia with asparaginase preparations: the impact of expensive chemotherapy | Haematologica
Asparaginase - Wikipedia
Managing toxicities with asparaginase-based therapies in adult ALL: summary of an ESMO Open–Cancer Horizons roundtable discussion - ScienceDirect
Alternative algorithm for L-asparaginase allergy in children with acute lymphoblastic leukemia. | Semantic Scholar
Use of PEG-asparaginase in newly diagnosed adults with standard-risk acute lymphoblastic leukemia compared with E. coli-asparaginase: a retrospective single-center study | Scientific Reports
Asparaginase Toxicities: Identification and Management in Patients With Acute Lymphoblastic Leukemia | ONS
Bubble plot of the incidence of allergic reactions (sum of allergies... | Download Scientific Diagram
Implementation of the asparaginase activity assessment technique for clinical use: experience of a Brazilian Center | Scientific Reports
Increase in peg-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemia | Leukemia
Proposed treatment algorithm after allergic reactions to front-line... | Download Scientific Diagram
Safety of mRNA-based COVID-19 vaccination in paediatric patients with a PEG-asparaginase allergy - EJC Paediatric Oncology
Increase in peg-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemia | Leukemia
Asparaginase Toxicities: Identification and Management in Patients With Acute Lymphoblastic Leukemia | ONS
(PDF) Alternative algorithm for L-asparaginase allergy in children with acute lymphoblastic leukemia | Selin Aytac - Academia.edu
Pharmacokinetics of very prolonged PEGasparaginase and Erwinia... | Download Scientific Diagram
